15 a) Histoire clinique, p.15 ,
23 a), p.23 ,
24 a) Tests cutanés et IgE spécifiques positifs pour un seul venin, p.24 ,
28 a) Le diagnostic positif, p.28 ,
A Controlled Trial of Immunotherapy in Insect Hypersensitivity, New England Journal of Medicine, vol.299, issue.4, pp.157-161, 1978. ,
DOI : 10.1056/NEJM197807272990401
Immunotherapy in Bee Sting Hypersensitivity., Allergy, vol.55, issue.6, pp.369-378, 1979. ,
DOI : 10.1016/0091-6749(77)90169-5
Clinical and immunologic observations in patients who stop venom immunotherapy, Journal of Allergy and Clinical Immunology, vol.77, issue.3, pp.435-442, 1986. ,
DOI : 10.1016/0091-6749(86)90177-6
Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety, Journal of Allergy and Clinical Immunology, vol.89, issue.2, pp.529-535, 1992. ,
DOI : 10.1016/0091-6749(92)90319-W
Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity: A meta-analysis, Clinical Therapeutics, vol.22, issue.3, pp.351-358, 2000. ,
DOI : 10.1016/S0149-2918(00)80039-9
Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses, Journal of Allergy and Clinical Immunology, vol.108, issue.6, pp.1027-1032, 2001. ,
DOI : 10.1067/mai.2001.119154
Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial, The Lancet, vol.361, issue.9362, pp.1001-1006, 2003. ,
DOI : 10.1016/S0140-6736(03)12827-9
Stinging insect hypersensitivity: A practice parameter update, Journal of Allergy and Clinical Immunology, vol.114, issue.4, pp.869-886, 2004. ,
DOI : 10.1016/j.jaci.2004.07.046
Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice, Allergy, vol.60, issue.1, pp.1459-1470, 2005. ,
DOI : 10.4049/jimmunol.166.5.3612
Allergies aux venins d'hyménoptères. Joinville-Le-Pont, Institut Français de Recherche en Allergologie, p.112, 1985. ,
Allergens in hymenoptera venom XII: how much protein is in a sting? Ann Allergy, avr, vol.52, issue.4, pp.276-278, 1984. ,
Diagnosis of Hymenoptera venom allergy, Allergy, vol.101, issue.74, pp.1339-1388, 2005. ,
DOI : 10.1046/j.1365-2222.1997.980914.x
Immunotherapy with Hymenoptera venoms., Allergy, vol.73, issue.6, pp.401-414, 1987. ,
DOI : 10.1016/0091-6749(80)90118-9
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.1987.tb00355.x/pdf
Wasp venom allergy and immunity, Ann Allergy. oct, vol.14, issue.5, pp.347-366, 1956. ,
A Case for Venom Treatment in Anaphylactic Sensitivity to Hymenoptera Sting, New England Journal of Medicine, vol.290, issue.22, pp.1223-1227, 1974. ,
DOI : 10.1056/NEJM197405302902204
Immunotherapy in bee-sting anaphylaxis. Use of honeybee venom, JAMA: The Journal of the American Medical Association, vol.231, issue.11, pp.1154-1156, 1975. ,
DOI : 10.1001/jama.231.11.1154
Stinging insect allergy: Natural history and modification with venom immunotherapy, Journal of Allergy and Clinical Immunology, vol.75, issue.6, pp.735-740, 1985. ,
DOI : 10.1016/0091-6749(85)90103-4
Insect sting allergy and venom immunotherapy: A model and a mystery, Journal of Allergy and Clinical Immunology, vol.115, issue.3, pp.439-447, 2005. ,
DOI : 10.1016/j.jaci.2005.01.005
Large local reactions from stinging insects: from epidemiology to management, Current Opinion in Allergy and Clinical Immunology, vol.9, issue.4, pp.334-337, 2009. ,
DOI : 10.1097/ACI.0b013e32832d0668
The diagnosis and management of anaphylaxis practice parameter: 2010 Update, Journal of Allergy and Clinical Immunology, vol.126, issue.3, pp.477-480, 2010. ,
DOI : 10.1016/j.jaci.2010.06.022
Epidemiology of insect-venom anaphylaxis, Current Opinion in Allergy and Clinical Immunology, vol.8, issue.4, pp.330-337, 2008. ,
DOI : 10.1097/ACI.0b013e32830638c5
Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic features, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.68, issue.10, pp.834-838, 1998. ,
DOI : 10.1016/0091-6749(81)90133-0
Bee venom allergy in beekeepers and their family members, Current Opinion in Allergy and Clinical Immunology, vol.5, issue.4, pp.343-347, 2005. ,
DOI : 10.1097/01.all.0000173783.42906.95
The natural history and epidemiology of insect venom allergy: clinical implications, Clinical & Experimental Allergy, vol.39, issue.10, pp.1467-76, 2009. ,
DOI : 10.1111/j.1365-2222.2009.03324.x
Shortness of interval between two stings as risk factor for developing Hymenoptera venom allergy, Allergy, vol.25, issue.10, pp.894-896, 1994. ,
DOI : 10.1016/0091-6749(78)90231-2
Clinical and immunological surveys in bee keepers, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.36, issue.4, pp.331-342, 1982. ,
DOI : 10.1016/0091-6749(80)90118-9
Diagnosis and treatment of anaphylactic reactions to Hymenoptera stings in children, The Journal of Pediatrics, vol.97, issue.2, pp.177-184, 1980. ,
DOI : 10.1016/S0022-3476(80)80470-7
Influence of total and specific IgE, serum tryptase, and age on severity of allergic reactions to Hymenoptera stings, Allergy, vol.64, issue.2, pp.222-228, 2011. ,
DOI : 10.1111/j.1398-9995.2010.02470.x
Clinical Effectiveness of Hymenoptera Venom Immunotherapy: A Prospective Observational Multicenter Study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity, PLoS ONE, vol.116, issue.5, p.63233, 2013. ,
DOI : 10.1371/journal.pone.0063233.t002
Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: Importance of baseline serum tryptase???a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity, Journal of Allergy and Clinical Immunology, vol.124, issue.5, pp.1047-1054, 2009. ,
DOI : 10.1016/j.jaci.2009.08.027
European hornet (Vespa crabro) sting: a new risk factor for life-threatening reaction in hymenoptera allergic patients?, Eur Ann Allergy Clin Immunol. juin, vol.35, issue.6, pp.199-203, 2003. ,
Cardiovascular disease and anaphylaxis, Current Opinion in Allergy and Clinical Immunology, vol.7, issue.4, pp.337-341, 2007. ,
DOI : 10.1097/ACI.0b013e328259c328
Fatal anaphylaxis: postmortem findings and associated comorbid diseases, Annals of Allergy, Asthma & Immunology, vol.98, issue.3, pp.252-257, 2007. ,
DOI : 10.1016/S1081-1206(10)60714-4
The human heart as a shock organ in anaphylaxis, Novartis Found Symp, vol.257, pp.133-149, 2004. ,
Hymenoptera venom anaphylaxis and cardiovascular disease, Der Hautarzt, vol.12, issue.3, pp.206-208, 2008. ,
DOI : 10.1016/0140-6736(92)93314-D
Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy, Annals of Allergy, Asthma & Immunology, vol.101, issue.4, pp.426-430, 2008. ,
DOI : 10.1016/S1081-1206(10)60321-3
Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy? Curr Allergy Asthma Rep, mars, vol.8, issue.1, pp.37-44, 2008. ,
Mastocytosis and Hymenoptera venom allergy, Current Opinion in Allergy and Clinical Immunology, vol.6, issue.4, pp.284-288, 2006. ,
DOI : 10.1097/01.all.0000235903.10548.63
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients, Allergy, vol.17, issue.1 part 1, pp.226-232, 2008. ,
DOI : 10.1001/archderm.1962.01590080087011
Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy, Allergy, vol.110, issue.9, pp.1237-1245, 2009. ,
DOI : 10.1016/S1081-1206(10)60305-5
Platelet-Activating Factor, PAF Acetylhydrolase, and Severe Anaphylaxis, New England Journal of Medicine, vol.358, issue.1, pp.28-35, 2008. ,
DOI : 10.1056/NEJMoa070030
Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis, Journal of Allergy and Clinical Immunology, vol.131, issue.1, pp.144-149, 2013. ,
DOI : 10.1016/j.jaci.2012.08.016
Classification of allergic reactions responsible for clinical hypersensitivity and disease. Clinical aspects of immunology. Oxford (UK): Oxford University Pess: Gell RR editors, pp.575-596, 1968. ,
Anti-inflammatory Effect of Glyteer, Journal of Pharmacological Sciences, vol.149, issue.157, 1990. ,
Diagnosis and Treatment of Insect Sensitivity, Journal of Asthma Research, vol.177, issue.4, pp.331-333, 1966. ,
DOI : 10.1056/NEJM195908202610803
Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines, Clinical & Experimental Allergy, vol.107, issue.(S, pp.1201-1221, 2011. ,
DOI : 10.1067/mai.2001.111852
Cross-reacting carbohydrate determinants and hymenoptera venom allergy, Current Opinion in Allergy and Clinical Immunology, vol.13, issue.4, pp.360-364, 2013. ,
DOI : 10.1097/ACI.0b013e328362c544
Insect sting allergy--clinical aspects, diagnosis and therapy], Wien Med Wochenschr. 15 avr, vol.139, pp.6-7150, 1989. ,
venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5, Allergy, vol.61, issue.4, pp.543-548, 2009. ,
DOI : 10.1159/000234924
Mechanisms of immunotherapy: IgG revisited, Current Opinion in Allergy and Clinical Immunology, vol.4, issue.4, pp.313-318, 2004. ,
DOI : 10.1097/01.all.0000136753.35948.c0
Suivi immunologique des désensibilisations aux venins d'hyménoptères. Intérêt du test de Maunsell. Revue Française d'Allergologie et d'Immunologie Clinique, oct, vol.33, issue.4, pp.274-283, 1993. ,
DOI : 10.1016/s0335-7457(05)80046-2
Use of CD63 expression as marker of in vitro basophil activation in identifying the culprit in insect venom allergy, J Investig Allergol Clin Immunol, vol.14, issue.1, pp.10-16, 2004. ,
Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results, Clinical & Experimental Allergy, vol.39, issue.11, pp.1730-1737, 2009. ,
DOI : 10.1111/j.1365-2222.2009.03347.x
Emergency treatment of allergic reactions to Hymenoptera stings, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.42, issue.3, pp.281-288, 1991. ,
DOI : 10.1016/0091-6749(85)90103-4
A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody, J Immunol. août, vol.101, issue.2, pp.317-324, 1968. ,
Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever, The American Journal of Medicine, vol.44, issue.4, pp.514-524, 1968. ,
DOI : 10.1016/0002-9343(68)90052-1
Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy, Journal of Allergy and Clinical Immunology, vol.69, issue.6, pp.489-493, 1982. ,
DOI : 10.1016/0091-6749(82)90172-5
Allergen-specific IgG4 in atopic disease, Allergy, vol.166, issue.87, pp.559-569, 1993. ,
DOI : 10.1093/infdis/165.6.1158
Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings, Clinical & Experimental Allergy, vol.39, issue.6, pp.883-889, 2009. ,
DOI : 10.1111/j.1365-2222.2009.03230.x
Venom immunotherapy in the Hymenoptera-allergic pregnant patient, Journal of Allergy and Clinical Immunology, vol.85, issue.4, pp.709-712, 1990. ,
DOI : 10.1016/0091-6749(90)90188-A
Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.52, issue.9, pp.1216-1220, 2003. ,
DOI : 10.1034/j.1398-9995.1999.t01-1-00882.x
Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis, Journal of Allergy and Clinical Immunology, vol.99, issue.1, pp.153-154, 1997. ,
DOI : 10.1016/S0091-6749(97)70314-2
How much specific is the association between hymenoptera venom allergy and mastocytosis?, Allergy, vol.113, issue.9, pp.1379-1382, 2009. ,
DOI : 10.1111/j.1398-9995.2007.01569.x
Use of ??-blockers during immunotherapy for Hymenoptera venom allergy, Journal of Allergy and Clinical Immunology, vol.115, issue.3, pp.606-610, 2005. ,
DOI : 10.1016/j.jaci.2004.11.012
Insect sting allergy with negative venom skin test responses, Journal of Allergy and Clinical Immunology, vol.107, issue.5, pp.897-901, 2001. ,
DOI : 10.1067/mai.2001.114706
Timing of venom skin tests and IgE determinations after insect sting anaphylaxis, Journal of Allergy and Clinical Immunology, vol.100, issue.2, pp.182-184, 1997. ,
DOI : 10.1016/S0091-6749(97)70222-7
Negative venom skin test results in patients with histories of systemic reaction to a sting, Journal of Allergy and Clinical Immunology, vol.112, issue.3, pp.495-498, 2003. ,
DOI : 10.1016/S0091-6749(03)01537-9
Guidelines for management of people with histories of insect sting anaphylaxis and subsequent negative venom skin tests, Journal of Allergy and Clinical Immunology, vol.113, issue.2, p.364, 2004. ,
DOI : 10.1016/j.jaci.2003.11.028
Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols, Clinical & Experimental Allergy, vol.3, issue.3, pp.226-230, 1993. ,
DOI : 10.1111/j.1365-2222.1991.tb01659.x
Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy, J Investig Allergol Clin Immunol, vol.16, issue.2, pp.79-85, 2006. ,
Rush hymenoptera venom immunotherapy is efficacious and safe, J Investig Allergol Clin Immunol, vol.16, issue.4, pp.232-238, 2006. ,
Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol, Journal of Allergy, vol.91, issue.4, 2012. ,
DOI : 10.1016/S1081-1206(10)61689-4
Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.323, issue.1, pp.58-64, 2003. ,
DOI : 10.1056/NEJM199012063232305
Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.34, issue.6, pp.59-65, 1992. ,
DOI : 10.1016/0091-6749(86)90405-7
Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: A prospective, randomized, placebo-controlled trial??????????????????, Journal of Allergy and Clinical Immunology, vol.100, issue.4, pp.458-463, 1997. ,
DOI : 10.1016/S0091-6749(97)70135-0
Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy, Journal of Allergy and Clinical Immunology, vol.107, issue.1, pp.81-86, 2001. ,
DOI : 10.1067/mai.2001.111852
Practical Considerations in Venom Immunotherapy, Allergy and Asthma Proceedings, vol.18, issue.2, pp.79-83, 1997. ,
DOI : 10.2500/108854197778605518
Side-effects of insect venom immunotherapy:results from an EAACI multicenter study, Allergy, vol.98, issue.11, pp.1005-1010, 2000. ,
DOI : 10.1016/S0091-6749(96)70224-5
Venom immunotherapy for preventing allergic reactions to insect stings, Cochrane Database of Systematic Reviews, vol.49, issue.4, p.8838, 2012. ,
DOI : 10.1111/j.1398-9995.1994.tb02660.x
Specific immunotherapy using Hymenoptera venom: systematic review, Sao Paulo Medical Journal, vol.110, issue.1, pp.30-37, 2010. ,
DOI : 10.1067/mai.2002.125827
URL : http://www.scielo.br/pdf/spmj/v128n1/07.pdf
A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen?? for the treatment of bee and wasp venom allergy., Health Technology Assessment, vol.16, issue.12, pp.1-110, 2012. ,
DOI : 10.3310/hta16120
Insect sting fatality 9 years after venom treatment (venom allergy, fatality), Journal of Allergy and Clinical Immunology, vol.107, issue.5, p.925, 2001. ,
DOI : 10.1067/mai.2001.114985
Quoi de neuf dans l'allergie aux venins d'hyménoptères ? Une revue critique de la littérature récente, 2000. ,
DOI : 10.1016/s0335-7457(01)00089-2
Discontinuing venom immunotherapy: Extended observations??????????????????, Journal of Allergy and Clinical Immunology, vol.101, issue.3, pp.298-305, 1998. ,
DOI : 10.1016/S0091-6749(98)70239-8
Survey of patients after discontinuing venom immunotherapy, Journal of Allergy and Clinical Immunology, vol.105, issue.2, pp.385-390, 2000. ,
DOI : 10.1016/S0091-6749(00)90092-7
Fatal insect allergy after discontinuation of venom immunotherapy, Journal of Allergy and Clinical Immunology, vol.107, issue.5, pp.925-926, 2001. ,
DOI : 10.1067/mai.2001.115095
Duration of venom immunotherapy, J Allergy Clin Immunol. févr, vol.99, issue.2, pp.271-272, 1997. ,
Long-term protection after stopping venom immunotherapy: Results of re-stings in 200 patients??????????????????, Journal of Allergy and Clinical Immunology, vol.101, issue.5, pp.606-612, 1998. ,
DOI : 10.1016/S0091-6749(98)70167-8
Long-term outcome after venom immunotherapy, Current Opinion in Allergy and Clinical Immunology, vol.10, issue.4, pp.337-341, 2010. ,
DOI : 10.1097/ACI.0b013e32833bc0ba
Stinging insect hypersensitivity: A practice parameter update 2011, Journal of Allergy and Clinical Immunology, vol.127, issue.4, pp.852-854, 2011. ,
DOI : 10.1016/j.jaci.2011.01.025
Chapter 4: Stinging insect allergy and venom immunotherapy, Allergy and Asthma Proceedings, vol.33, issue.3, pp.12-14, 2012. ,
DOI : 10.2500/aap.2012.33.3534